Relias Media

Relias Media, a division of Relias, offers healthcare professionals access to medical information, publications, and continuing education aimed at enhancing patient care and outcomes. Previously referred to as AHC Media, Relias Media has a rich history of supporting professional growth through its acclaimed content in emergency medicine, clinical medicine, and hospital management.

National, Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#496039

United States

#220974

Health/Health

#4204

Traffic sources

Monthly visitors

Articles

Early Preoperative Antibiotics Before Appendectomy

1 week ago | reliasmedia.com | Jake Scott

By Jake Scott, MDSynopsis: Pre-incision treatment did not reduce intra-operative perforation, and likewise did not change purulent contamination, peri-appendicular abscess, or histologic gangrene. It did lower 30-day surgical-site infection (SSI) (1.6% vs. 3.2%; P = 0.03) and re-intervention for SSI (0.3% vs. 1.1%), but the effect was marginally significant, giving a number-needed-to-treat of 63 for any SSI and 125 for a re-intervention. Source: Jalava K, Sallinen V, Lampela H, et al.
Research Examines Which Patients Discontinue IUDs in Pre- and…

2 weeks ago | reliasmedia.com | Melinda Young

By Melinda YoungIntrauterine devices (IUDs) have become more popular in the United States in the years since President Donald Trump first was elected and in the years following the U.S. Supreme Court’s 2022 decision to overturn Roe v.
Gepotidacin Tablets (Blujepa)

2 months ago | reliasmedia.com | William Elliott |James Chan

By William Elliott, MD, FACP, and James Chan, PharmD, PhDThe U.S. Food and Drug Administration (FDA) has approved gepotidacin, a first-in-class antibacterial medication for the treatment of uncomplicated urinary tract infections (uUTIs). Gepotidacin is an oral triazaacenaphthylene antibiotic that inhibits two essential enzymes in bacterial deoxyribonucleic acid (DNA) replication. It will be distributed by GlaxoSmithKline as Blujepa.
Uncomplicated Pediatric Appendicitis: Antibiotics or Appendectomy?

Feb 14, 2025 | reliasmedia.com | Philip R. Fischer

By Philip R. Fischer, MD, DTM&HSynopsis: Some patients with acute uncomplicated appendicitis do well with initial antibiotic treatment and do not require surgical appendectomy. However, as with adults, approximately one-third of antibiotic-treated children eventually will require surgical removal of the appendix despite the initial short-term success of medical management. Source: St Peter SD, Noel-MacDonnell JR, Hall NJ, et al.
Interventions for Pain During Office Endometrial Biopsy

Jan 15, 2025 | reliasmedia.com | Rebecca Allen

By Rebecca H. Allen, MD, MPH, EditorSynopsis: In this randomized controlled trial, the use of transcutaneous electric nerve stimulation during endometrial biopsy did not clinically significantly reduce pain compared to placebo (median [interquartile range], 50 mm [20 mm to 80 mm] vs. 60 mm [40 mm to 100 mm]; P = 0.039), but was associated with increased satisfaction with the procedure. Source: Wu J, Lim S, Scott A, et al.
Some States Upend Maternal Mortality Committees and Investigations

Jan 6, 2025 | reliasmedia.com | Melinda Young

By Melinda YoungEXECUTIVE SUMMARYMaternal mortality review committees (MMRCs) are facing changes that could affect how maternal deaths are investigated and reported. This could lead to fewer initiatives to lower maternal mortality and morbidity rates and also mask could increases in abortion-ban states. Georgia dismissed all members of its MMRC after ProPublica published articles about two Georgian women who died because of the state’s abortion ban.
Pink Eye: Do Antibiotics Matter?

Nov 20, 2024 | reliasmedia.com | Philip R. Fischer

By Philip R. Fischer, MD, DTM&H SYNOPSIS: Acute infectious conjunctivitis, commonly referred to as pink eye, is common in children and is caused by bacteria more often than by viruses. Nonetheless, neither the clinical course of uncomplicated cases nor the spread of infection to peers is significantly altered by treatment with topical antibiotics or by exclusion of infected children from daycare and school settings. SOURCE: Frost HM, Jenkins TC, Meece JC, et al.
21st Century Cures Act May Help Drive Innovation in Case Management

Nov 18, 2024 | reliasmedia.com | Melinda Young

21st Century Cures Act May Help Drive Innovation in Case Management By Melinda YoungOne of the less well-known aspects of the 21st Century Cures Act is how it forces all electronic health records (EHRs) to communicate health data between health systems in standardized language. This could help revolutionize the continuum of care and the way healthcare entities communicate with each other.
Claims Management's Next Frontier Is Data-Driven Claims Revolution

Nov 1, 2024 | reliasmedia.com | Melinda Young

Claims Management's Next Frontier Is Data-Driven Claims Revolution Human empathy still neededBy Melinda YoungThe future of claims management will be in the hands of technology, including artificial intelligence (AI) as cost-effective, efficient technological strategies rise to the forefront of the industry.
Abortion Access and Pregnancy Dangers Continue

Oct 30, 2024 | reliasmedia.com | Melinda Young

Abortion Access and Pregnancy Dangers Continue How the Dobbs Decision Has Changed Abortion Access and Care in the United States State Shield Law Led to More People Accessing Medication Abortion Care of Cancer Patients and People with Chronic Illnesses in Jeopardy Since Dobbs Study Suggests Some EC Clients Interested in Implants When They Have Access Routine, Opt-Out Screening for Syphilis in Emergency Departments Succeeds Doxy-PEP Could Be Prevention Strategy for Some Patients...